GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acepodia Inc (ROCO:6976) » Definitions » EV-to-Revenue

Acepodia (ROCO:6976) EV-to-Revenue : (As of May. 27, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Acepodia EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Acepodia's enterprise value is NT$9,629.47 Mil. Acepodia's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was NT$0.00 Mil. Therefore, Acepodia's EV-to-Revenue for today is .

The historical rank and industry rank for Acepodia's EV-to-Revenue or its related term are showing as below:

ROCO:6976' s EV-to-Revenue Range Over the Past 10 Years
Min: 544.45   Med: 623.05   Max: 747.78
Current: 580.33

During the past 4 years, the highest EV-to-Revenue of Acepodia was 747.78. The lowest was 544.45. And the median was 623.05.

ROCO:6976's EV-to-Revenue is ranked worse than
92.97% of 1038 companies
in the Biotechnology industry
Industry Median: 8.145 vs ROCO:6976: 580.33

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Acepodia's stock price is NT$27.60. Acepodia's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was NT$0.00. Therefore, Acepodia's PS Ratio for today is .


Acepodia EV-to-Revenue Historical Data

The historical data trend for Acepodia's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acepodia EV-to-Revenue Chart

Acepodia Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- - - 807.58

Acepodia Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial - - - - 807.58

Competitive Comparison of Acepodia's EV-to-Revenue

For the Biotechnology subindustry, Acepodia's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acepodia's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acepodia's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Acepodia's EV-to-Revenue falls into.



Acepodia EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Acepodia's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=9629.469/0
=

Acepodia's current Enterprise Value is NT$9,629.47 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Acepodia's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acepodia  (ROCO:6976) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Acepodia's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=27.60/0
=

Acepodia's share price for today is NT$27.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2023 was NT$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acepodia EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Acepodia's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Acepodia (ROCO:6976) Business Description

Traded in Other Exchanges
N/A
Address
17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175
Acepodia Inc is a clinical stage biotechnology company engaged to develop innovative highly effective first-in-class cell therapies by using Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.

Acepodia (ROCO:6976) Headlines

No Headlines